Jose G. Montoya

Publication Details

  • A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient TRANSPLANT INFECTIOUS DISEASE Walia, R., Montoya, J. G., Visvesvera, G. S., Booton, G. C., Doyle, R. L. 2007; 9 (1): 51-54

    Abstract:

    Acanthamoeba species are known to cause 2 well-described entities: (1) granulomatous amoebic encephalitis (GAE), which usually affects immunocompromised hosts, and (2) keratitis, which typically follows trauma associated with contamination of water or contact lenses. Less common manifestations include pneumonitis and a subacute granulomatous dermatitis. We describe a case of granulomatous dermatitis secondary to Acanthamoeba infection in a lung transplant recipient and a successful outcome following treatment with lipid formulation of amphotericin B and voriconazole. We believe this is the second case report describing disseminated Acanthamoeba infection in a lung transplant recipient. We also describe successful outcome with a combination of lipid formulation of amphotericin B and voriconazole, drugs that have not been previously reported to treat Acanthamoeba.

    View details for DOI 10.1111/j.1399-3062.2006.00159.x

    View details for Web of Science ID 000244957300011

    View details for PubMedID 17313473

Stanford Medicine Resources:

Footer Links: